Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approval for Medtronic tissue heart valve:

This article was originally published in Clinica

Executive Summary

The US FDA has granted marketing approval for Medtronic's Mosaic porcine tissue heart valve. The device is a reduced-profile valve incorporating a flexible stent. It incorporates two Medtronic proprietary technologies: alpha-amino oleic acid treatment and the physiological fixation process. The company intends to delay launching the product until later this year due to "unprecedented demand" for its existing tissue valve range. Meantime it is increasing valve production to meet demand.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel